↓ Skip to main content

Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation

Overview of attention for article published in medRxiv, March 2021
Altmetric Badge

Mentioned by

news
75 news outlets
blogs
2 blogs
policy
3 policy sources
twitter
299 X users
patent
1 patent
wikipedia
6 Wikipedia pages

Citations

dimensions_citation
228 Dimensions

Readers on

mendeley
239 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation
Published in
medRxiv, March 2021
DOI 10.1101/2021.03.07.21252647
Pubmed ID
Authors

Xianding Deng, Miguel A Garcia-Knight, Mir M. Khalid, Venice Servellita, Candace Wang, Mary Kate Morris, Alicia Sotomayor-González, Dustin R Glasner, Kevin R Reyes, Amelia S. Gliwa, Nikitha P. Reddy, Claudia Sanchez San Martin, Scot Federman, Jing Cheng, Joanna Balcerek, Jordan Taylor, Jessica A Streithorst, Steve Miller, G. Renuka Kumar, Bharath Sreekumar, Pei-Yi Chen, Ursula Schulze-Gahmen, Taha Y. Taha, Jennifer Hayashi, Camille R. Simoneau, Sarah McMahon, Peter V. Lidsky, Yinghong Xiao, Peera Hemarajata, Nicole M. Green, Alex Espinosa, Chantha Kath, Monica Haw, John Bell, Jill K. Hacker, Carl Hanson, Debra A. Wadford, Carlos Anaya, Donna Ferguson, Liana F. Lareau, Phillip A. Frankino, Haridha Shivram, Stacia K. Wyman, Melanie Ott, Raul Andino, Charles Y. Chiu

Abstract

We identified a novel SARS-CoV-2 variant by viral whole-genome sequencing of 2,172 nasal/nasopharyngeal swab samples from 44 counties in California. Named B.1.427/B.1.429 to denote its 2 lineages, the variant emerged around May 2020 and increased from 0% to >50% of sequenced cases from September 1, 2020 to January 29, 2021, exhibiting an 18.6-24% increase in transmissibility relative to wild-type circulating strains. The variant carries 3 mutations in the spike protein, including an L452R substitution. Our analyses revealed 2-fold increased B.1.427/B.1.429 viral shedding in vivo and increased L452R pseudovirus infection of cell cultures and lung organoids, albeit decreased relative to pseudoviruses carrying the N501Y mutation found in the B.1.1.7, B.1.351, and P.1 variants. Antibody neutralization assays showed 4.0 to 6.7-fold and 2.0-fold decreases in neutralizing titers from convalescent patients and vaccine recipients, respectively. The increased prevalence of a more transmissible variant in California associated with decreased antibody neutralization warrants further investigation.

X Demographics

X Demographics

The data shown below were collected from the profiles of 299 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 239 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 239 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 37 15%
Student > Master 31 13%
Student > Ph. D. Student 25 10%
Student > Bachelor 19 8%
Student > Doctoral Student 11 5%
Other 32 13%
Unknown 84 35%
Readers by discipline Count As %
Medicine and Dentistry 35 15%
Biochemistry, Genetics and Molecular Biology 31 13%
Immunology and Microbiology 24 10%
Agricultural and Biological Sciences 17 7%
Chemistry 7 3%
Other 38 16%
Unknown 87 36%